Opko Health

Yahoo Finance • 2 months ago

OPKO Health (OPK) Advances EBV Vaccine and GLP-1 Pipeline While Streamlining Diagnostics

We recently published 12 Best Healthcare Stocks to Buy Under $30. OPKO Health, Inc. (NASDAQ:OPK) is one of the best healthcare stocks. OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company with operations in diagnostics, phar... Full story

Yahoo Finance • 2 months ago

Opko Health earnings missed by $0.08, revenue fell short of estimates

Investing.com - Opko Health (NASDAQ: OPK) reported second quarter EPS of $-0.190, $0.08 worse than the analyst estimate of $-0.113. Revenue for the quarter came in at $156.8M versus the consensus estimate of $165.7M. Opko Health’s stock... Full story

Yahoo Finance • 2 months ago

OPKO Health Inc (NASDAQ:OPK) Q2 2025 Earnings Miss Estimates, Stock Plunges 7.8%

OPKO Health Inc (NASDAQ:OPK [https://www.chartmill.com/stock/quote/OPK]) reported its second-quarter 2025 financial results, missing analyst expectations on both revenue and earnings per share (EPS). The company’s stock fell sharply in aft... Full story

Yahoo Finance • 2 months ago

OPKO Health Reports Second Quarter 2025 Business Highlights and Financial Results

OPKO Health, Inc. Conference call begins at 4:30 p.m. Eastern time today MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 3... Full story

Yahoo Finance • 3 months ago

OPKO Health’s (OPK) Oral GLP-2 Analog Selected for a Poster Presentation in Collaboration with Entera Bio (ENTX)

OPKO Health, Inc. (NASDAQ:OPK) is one of the Best American Penny Stocks to Buy According to Analysts. On July 8, OPKO Health, Inc. (NASDAQ:OPK) in collaboration with Entera Bio Ltd. (NASDAQ: ENTX) announced the selection of their Oral GLP-... Full story

Yahoo Finance • 3 months ago

H.C. Wainwright Reiterates a Buy Rating on Opko Health (OPK), Keeps the PT at $3

Opko Health Inc. (NASDAQ:OPK) is one of the 13 Stocks Under $5 With High Upside Potential. On May 1, analyst Yi Chen of H.C. Wainwright reiterated a Buy rating on Opko Health Inc. (NASDAQ:OPK), retaining the price target of $3.00. Despite... Full story

Yahoo Finance • 4 months ago

OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

MIAMI, June 25, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) today announced its participation in the 3rd Annual Piper Sandler Obesity Symposium being held virtually on June 26, 2025. Management will be participating in a fir... Full story

Yahoo Finance • 4 months ago

OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development

Will provide expertise across ModeX’s portfolio of next generation multispecific antibodies for complex diseases involving the immune system, including cancer ModeX’s promising immunology pipeline includes first-in class drugs with two as... Full story

Yahoo Finance • 5 months ago

OPKO Health Inc (OPK) Q1 2025 Earnings Call Highlights: Strategic Moves and Financial ...

Diagnostics Segment Revenue: $102.8 million in Q1 2025, including $25.1 million from assets being sold to LabCorp, compared to $126.9 million in Q1 2024. Diagnostics Segment Costs and Expenses: $126.8 million in Q1 2025, including $32.4 mi... Full story

Yahoo Finance • 6 months ago

OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025

OPKO Health, Inc. MIAMI, April 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on Wednesd... Full story

Yahoo Finance • 6 months ago

OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program

MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- OPKOHealth,Inc.(NASDAQ:OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company’s existing common stock repurchase program, bringing the aggregat... Full story

Yahoo Finance • 7 months ago

OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders

MIAMI and JERUSALEM, March 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, entered into a collaboration and... Full story

Yahoo Finance • 7 months ago

OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results

MIAMI, Feb. 27, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and 12 months ended December 31, 2024. Highlights from the fourth quarter of 2024 and recent weeks... Full story

Yahoo Finance • 8 months ago

OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025

MIAMI, Feb. 13, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and 12 months ended December 31, 2024 after the close of the U.S. financial markets on Thursday, Febru... Full story

Yahoo Finance • last year

NextPlat Secures Four-Year Extension of OPKO Healthcare E-Commerce Program in China and Agrees to the Expansion of the Program into Japan

Company to Support the Sales and Marketing of OPKO's Products on Additional E-Commerce Platforms and on Social Media Channels in China and into the Large Japanese Health and Wellness Market COCONUT GROVE, Fla. and MIAMI, Oct. 7, 2024 /PRN... Full story

Yahoo Finance • last year

Roth analysis: Has volatility created a trigger warning for stocks?

Investing.com - The financial markets have experienced a roller coaster ride of late, prompting analysts at Roth to issue a technical strategy update. Despite ending last week down just 0.04%, the S&P 500's minor dip feels like a victory... Full story

Yahoo Finance • 2 years ago

NextPlat Receives Initial Approvals to Launch OPKO Health-Branded Storefront on Alibaba's Tmall Global Platform in China

E-Commerce Storefront to Initially Support Sales of up to 40 Personal Health and Wellness Products; Final International Certifications and Approvals Required for Formal Launch Expected This Quarter COCONUT GROVE, Fla., Feb. 5, 2024 /PRNew... Full story

Yahoo Finance • 2 years ago

BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing

ELMWOOD PARK, N.J., Nov. 28, 2023 /PRNewswire/ -- BioReference® Health, LLC (BRH), a leading specialty laboratory in the United States, announced a strategic collaboration with Prognos Health, a pioneer in providing accessible, quality rea... Full story

Yahoo Finance • 2 years ago

New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

MIAMI, Nov. 02, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) presented late-breaking clinical data on RAYALDEE® extended-release calcifediol (ERC) at the American Society of Nephrology (ASN) Kidney Week in Philadelphia today.... Full story

Yahoo Finance • 2 years ago

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

MIAMI, Oct. 25, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) will present late-breaking clinical data on RAYALDEE® extended-release calcifediol (ERC) at the American Society of Nephrology (ASN) Kidney Week in Philadelphia on... Full story